Weilei Hu
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- Extracellular vesicles in disease 3
- RNA modifications and cancer 2
- Epigenetics and DNA Methylation 2
- Oncology 6
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Guosheng Wang (10 shared papers)Yibing Xu (3 shared papers)Meihua Sui (2 shared papers)Dongsheng Huang (1 shared paper)Yihan Yao (3 shared papers)Xiao‐Fang Yu (2 shared papers)Xin Shou (2 shared papers)Tingting Ye (1 shared paper)
- Journals
- Cancers (2 papers)iScience (1 paper)Molecular Oncology (1 paper)Aging (1 paper)Frontiers in Genetics (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Weilei Hu
11 papers receiving 640 citations
Peers
Comparison fields: 5 of 75
- Immunology 298
- Cancer Research 167
- Oncology 249
- Molecular Biology 312
- Biotechnology 24
Countries citing papers authored by Weilei Hu
This map shows the geographic impact of Weilei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weilei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weilei Hu more than expected).
Fields of papers citing papers by Weilei Hu
This network shows the impact of papers produced by Weilei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weilei Hu. The network helps show where Weilei Hu may publish in the future.
Co-authors
The 21 scholars most cited alongside Weilei Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 294 | |
| 2 | 2019 | 120 | |
| 3 | 2019 | 110 | |
| 4 | 1992 | 34 | |
| 5 | 2020 | 28 | |
| 6 | 2018 | 15 | |
| 7 | 2016 | 13 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 11 | |
| 10 | 2020 | 11 | |
| 11 | 2019 | 1 |
About Weilei Hu
Weilei Hu is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 11 papers that have together received 650 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Extracellular vesicles in disease (3 papers), Ferroptosis and cancer prognosis (3 papers), RNA modifications and cancer (2 papers), Epigenetics and DNA Methylation (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), MicroRNA in disease regulation (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Immunology (298 citations), Cancer Research (167 citations), Oncology (249 citations), Molecular Biology (312 citations) and Biotechnology (24 citations). Weilei Hu has collaborated with scholars based in China, United States and India. Frequent co-authors include Guosheng Wang, Yibing Xu, Meihua Sui, Dongsheng Huang, Yihan Yao, Xiao‐Fang Yu, Xin Shou, Tingting Ye, Ashim K. Datta and Yian Wang. Their work appears in journals such as Cancers, iScience, Molecular Oncology, Aging and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.